# Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth

> **NCT02793557** · PHASE1,PHASE2 · COMPLETED · sponsor: **Follicum AB** · enrollment: 44 (actual)

## Conditions studied

- Hypertrichosis
- Alopecia
- Hirsutism

## Interventions

- **DRUG:** FOL-005
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02793557
- **Lead sponsor:** Follicum AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02793557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02793557, "Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02793557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
